|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0053 - 0.0060|
|52 Week Range||0.0031 - 0.1990|
|Beta (3Y Monthly)||0.52|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (4.32%)|
|1y Target Est||N/A|
The Physicians Consulting Service will commence immediately and will be part of RASCI’s value added services to all our current physicians engaged in RASCI’s services as well as other physicians that RASCI will seek out through its newly established inside sales channel.
LAS VEGAS, NV, Aug. 07, 2019 -- via NEWMEDIAWIRE -- CeCors, Inc. (OTC PINK: CEOS), a Company focused on the Health & Technology Sector as well as other Emerging.
The acquisition is part of a tax-free share for share exchange which will see CeCors, Inc. issue 400,000 Preferred “A” shares at $2.50 per share plus $500,000 on closing and additional preferred bonus shares upon meeting revenue milestones ranging from $100,000 per month to $500,000 in monthly revenues. Prior to closing, the Company will be filing an Amendment to its Articles of Incorporation to include special classes of preferred shares that will be used to complete the RASCi acquisitions as well as other contemplated target acquisitions and its upcoming private placement raise of $5M for preferred shares.
LAS VEGAS, NV, Aug. 01, 2019 -- via NEWMEDIAWIRE -- CeCors, Inc. (OTC:CEOS); a Company focused on the Health & Technology Sector as well as other Emerging Technologies, is.
In addition to launching its interactive website at www.cannmedlive.com, CannMedLive will also be launching two separate Apps in both Google Play and iTunes marketplace. The App will be free to medical cannabis users and physicians. The App will connect patients with physicians in a real-time live online format from the comfort and privacy of the patient’s own home. This enables a physician to conduct medical consults from either the web or with CannMedLive’s App through the patient’s smartphone. Physicians will also be able to review and keep track of a patient’s medical history and be able to conduct follow up consults, which are recommended under Health Canada’s regulations and standard practice for medical cannabis users.